Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study.
Zhou JY, Chen YX, Yuan HL, Xu YJ, Huang XB, Gao SJ, Zhang YC, Zhou F, Song XM, Luo Y, Yang JM, Li YH, Wang SQ, Dong YJ, Zhang X, Feng YM, Du X, Zhu H, Zhu ZM, Bi KH, Jiang M, Niu T, Wan DM, Chen Y, Liu L, Yi H, Chen YH, Wang FR, Zhang YY, Mo XD, Han W, Wang JZ, Wang Y, Chen H, Zhao XY, Chang YJ, Liu KY, Huang XJ, Zhang XH. Zhou JY, et al. Among authors: li yh. Bone Marrow Transplant. 2024 Nov 25. doi: 10.1038/s41409-024-02480-3. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39587323
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study.
Sun J, Zhang YC, Wei J, Xu YJ, Zhang Y, Li YH, Wu AQ, Fan L, Zhu Y, Liu FQ, Jiang ZX, Liu C, Jiang M, Qu JH, He PC, Wang J, Huang XB, Xiao R, Gao SJ, Guo Q, Wang SB, Li XP, Fan SJ, Sun LL, Xu LP, Huang XJ, Zhang XH. Sun J, et al. Among authors: li yh, li xp. Bone Marrow Transplant. 2024 Dec 2. doi: 10.1038/s41409-024-02485-y. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39622998
Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML.
Zhou JY, Wang S, Yuan HL, Xu YJ, Huang XB, Gao SJ, Zhang YC, Zhou F, Liu Y, Song XM, Cai Y, Liu XL, Luo Y, Yang LX, Yang JM, Wang LB, Li YH, Huang R, Wang SQ, Zhou M, Dong YJ, Wang Q, Zhang X, Feng YM, Du X, Ling W, Zhu H, Zhu ZM, Chen XL, Wang SY, Meng FK, Bi KH, Huang N, Jiang M, Niu T, Ji J, Wan DM, Bian ZL, Chen Y, Liu L, Yan XQ, Yang X, Yi H, Wei XD, Li X, Cheng Q, Yuan CL, Wang W, Zhou YH, Ye BD, Ding J, Wu YJ, Huang QS, Zhu XL, Chen YH, He Y, Wang FR, Zhang YY, Mo XD, Han W, Wang JZ, Wang Y, Chen H, Zhao XY, Chang YJ, Liu KY, Huang XJ, Zhang XH. Zhou JY, et al. Among authors: li yh, li x. Am J Hematol. 2023 Sep;98(9):1394-1406. doi: 10.1002/ajh.26999. Epub 2023 Jun 27. Am J Hematol. 2023. PMID: 37366294 Free article.
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
Zhao H, Wei J, Wei G, Luo Y, Shi J, Cui Q, Zhao M, Liang A, Zhang Q, Yang J, Li X, Chen J, Song X, Jing H, Li Y, Hao S, Wu W, Tan Y, Yu J, Zhao Y, Lai X, Yin ETS, Wei Y, Li P, Huang J, Wang T, Blaise D, Xiao L, Chang AH, Nagler A, Mohty M, Huang H, Hu Y. Zhao H, et al. J Hematol Oncol. 2020 May 4;13(1):42. doi: 10.1186/s13045-020-00873-7. J Hematol Oncol. 2020. PMID: 32366260 Free PMC article. Clinical Trial.
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial.
Zhao K, Lin R, Fan Z, Chen X, Wang Y, Huang F, Xu N, Zhang X, Zhang X, Xuan L, Wang S, Lin D, Deng L, Nie D, Weng J, Li Y, Zhang X, Li Y, Xiang AP, Liu Q. Zhao K, et al. J Hematol Oncol. 2022 Mar 7;15(1):22. doi: 10.1186/s13045-022-01240-4. J Hematol Oncol. 2022. PMID: 35255929 Free PMC article. Clinical Trial.
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Li P, Liu Y, Liang Y, Bo J, Gao S, Hu Y, Hu Y, Huang H, Huang X, Jing H, Ke X, Li J, Li Y, Liu Q, Lu P, Mei H, Niu T, Song Y, Song Y, Su L, Tu S, Wang J, Wu D, Wang Z, Xu K, Ying Z, Yang Q, Zhang Y, Shi F, Zhang B, Zhang H, Zhang X, Zhao M, Zhao W, Zhao X, Huang L, Zhu J, Qian W, Han W, Liang A. Li P, et al. Cancer Biol Med. 2023 Mar 2;20(2):129-46. doi: 10.20892/j.issn.2095-3941.2022.0585. Cancer Biol Med. 2023. PMID: 36861439 Free PMC article.
Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies.
Tu S, Luo X, Mei H, Hu Y, Liu Y, Li P, Zou D, Niu T, Xu K, Zhang X, Qiu L, Gao L, Gao G, Zhang L, Feng Y, Wang Y, Zhao M, Mi J, Hou M, Yang J, Huang H, Wang J, Hu Y, Zhao W, Wu D, Ma J, Li Y, Qian W, Huang X, Han W, Liang A. Tu S, et al. Chin Med J (Engl). 2024 Nov 20;137(22):2681-2683. doi: 10.1097/CM9.0000000000003379. Epub 2024 Nov 5. Chin Med J (Engl). 2024. PMID: 39497436 Free PMC article. No abstract available.
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy.
Mei H, Chen F, Han Y, Hou M, Huang H, Huang X, Li Y, Liang A, Liu Q, Niu T, Peng J, Qian W, Song Y, Wang J, Wang Y, Wu D, Xu K, Yang L, Yang R, Zhang L, Zhang L, Zhang X, Zhang X, Zhao W, Han W, Hu Y. Mei H, et al. Chin Med J (Engl). 2022 Jul 20;135(14):1639-1641. doi: 10.1097/CM9.0000000000002288. Chin Med J (Engl). 2022. PMID: 35984103 Free PMC article. No abstract available.
4,532 results